Skip to main content
Start of main content

House Hearing, 92nd Congress - Notification of initiation or discontinuance of drug manufacture: hearing before the Subcommittee on Public Health and Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-second Congress, first session, on H.R. 4749 and H.R. 8963, bills to amend the Federal Food, Drug, and Cosmetic Act to provide for a current listing of each drug manufactured, prepared, propagated, compounded, or processed by a registrant under that Act, and for other purposes, June 10, 1971.